36
Participants
Start Date
July 23, 2019
Primary Completion Date
December 2, 2020
Study Completion Date
December 2, 2020
DNL151
Oral repeating dose
Placebo
Oral repeating dose
Centre for Human Drug Research, Leiden
UZ Leuven, Leuven
PPD Clinical Research Unit, Orlando
Quest Research Institute, Farmington Hills
QPS, Leeuwarden
Royal Liverpool University Hospital, Liverpool
MAC Clinical Research, Manchester
Simbec-Orion Clinical Pharmacology, Merthyr Tydfil
Lead Sponsor
Biogen
INDUSTRY